Editorial

25th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Information image
Average (ratings)
No ratings
Your rating

Received:

Accepted:

Published online:

Open Access:

This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

The ISCP and team Singapore were extremely happy and proud to be able to curate key opinion leaders and multidisciplinary stakeholders to take part in our 25th Annual Scientific Meeting which was organised virtually on 24–25 July 2021.

We were joined by 1,770 delegates from 42 different counties and topics covered were of broad interest. The congress was spearheaded by cardiovascular specialists across multiple disciplines, including pharmacologists, cardiac physicians and surgeons, pharmacists, scientists, nurses and medical practitioners. The scientific programme focused on cardiovascular pharmacotherapy in disease management which is the core aim of the ISCP.

The abstracts reflect the quality of offerings and our prize winners fully deserved their recognition. I congratulate all the submitters and winners. Well done.

We would express our gratitude and thanks to our host the Singapore Cardiac Society and the many sponsor partners who made this event possible.

Our 26th Annual Scientific Meeting will be held in Bucharest on 27–29 October 2022. We hope to welcome you back to join us again next year.

Stay safe, stay engaged with ISCP.